ScreenerHero

PLUR Pluri Inc.

NAS · US · Healthcare · Biotechnology · pluri-biotech.com
1.040USD+5.05%Mkt Cap: 12.84M $P/E: —

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based c…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap12.84M USD
Enterprise Value44.93M USD
Revenue (TTM)1.02M USD
Gross Profit453.00K USD
Net Income (TTM)-23.82M USD
Revenue/Share0.10 USD
Last Price1.040 USD
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees92
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.52
PEG—
EV/EBITDA-1.84
EV/Revenue44.23
P/S12.03
P/B-0.47
EPS (TTM)-2.44
EPS (Forward)-1.90
52W Range
0.85005% of range4.870
52W High4.870 USD
52W Low0.8500 USD
Profitability
Gross Margin44.59%
Oper. Margin-1655.52%
EBITDA Margin0.00%
Profit Margin-2344.59%
ROE103.41%
ROA-95.75%
Growth
Revenue Growth-15.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.59M USD
CapEx (TTM)633.00K USD
FCF Margin-1190.63%
FCF Yield-94.22%
Net Debt27.11M USD
Net Debt/EBITDA-1.11
Balance Sheet
Debt/Equity-1.52
Current Ratio0.27
Quick Ratio0.24
Book Value/Sh-2.13 USD
Cash/Share0.63 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 25, 2019
Splits
Last Split1:8
Split DateApr 1, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.12.34M
Float6.12M
Insiders42.52%
Institutions20.68%
Short Interest
Short Ratio0.7d
Short % Float0.30%
Short % Out.0.16%
Shares Short19.90K
Short (prev mo.)15.51K
Technical
SMA 501.409 (-26.2%)
SMA 2002.582 (-59.7%)
Beta0.69
S&P 52W Chg15.78%
Avg Vol (30d)20.02K
Avg Vol (10d)16.18K
Technical Indicators
RSI (14)36.9
MACD-0.1346
MACD Signal-0.1504
MACD Hist.+0.0158
BB Upper1.360 USD
BB Middle1.110 USD
BB Lower0.8591 USD
BB Width45.17%
ATR (14)0.1169 USD
Vol Ratio (20d)4.42x